The susceptibility of non-fermentative Gram-negative bacilli to cefperazone and sulbactam compared with other antibacterial agents

International Journal of Antimicrobial Agents

Volumn 22, Issue 4, 2003, Pages 444-448

  Fu, Wang ^a   Demei, Zhu ^a   Shi, Wu ^a   Fupin, Hu ^a   Yingyuan, Zhang ^a  

^a FUDAN UNIVERSITY   (China)

Author keywords

Bacterial susceptibility testing; Cefoperazone sulbactam; Non fermentative Gram negative bacilli

Indexed keywords

AMIKACIN; AMOXICILLIN; AMPICILLIN; ANTIINFECTIVE AGENT; AZTREONAM; CEFOPERAZONE; CEFOTAXIME; CEFTAZIDIME; CEFTRIAXONE; CHLORAMPHENICOL DERIVATIVE; CIPROFLOXACIN; CLAVULANATE POTASSIUM; COTRIMOXAZOLE; GENTAMICIN; IMIPENEM; MEROPENEM; PANIPENEM; PIPERACILLIN; SULBACTAM; SULTAMICILLIN; TICARCILLIN;

ACINETOBACTER; ALCALIGENES; ANTIBACTERIAL ACTIVITY; ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL STRAIN; BACTERIUM ISOLATE; BURKHOLDERIA; CONTROLLED STUDY; DATA ANALYSIS; DRUG SENSITIVITY; FERMENTATION; FLAVOBACTERIUM; GRAM NEGATIVE BACTERIUM; NONHUMAN; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA; STENOTROPHOMONAS MALTOPHILIA;

EID: 0141457666     PISSN: 09248579     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0924-8579(03)00109-2     Document Type: Article

References (12)

1. Barry A.L., Jones R.N. Criteria for disk susceptibility tests and quality control guidelines for the cefoperazone-sulbactam combination. J. Clin. Microbiol. 26:1988;13-17.
2. NCCLS. Performance standards for antimicrobial disk susceptibility tests; approved standard-seventh edition, M100-S10(M7), January 2000.
3. Williams J.D. Beta-lactamase inhibition and in vitro activity of sulbactam and sulbactam/cefoperazone. Clin. Infect. Dis. 24:1997;494-497.
4. Dai ZY, Liu YK, Wang F, editors. Antimicrobial Agents in Practice. 2nd ed. Shanghai Science and Technology Publishing House, 1998. p. 139-140, 164.
5. Fass R.J., Gregory W.W., D'Amato R.F., Matsen J.M., Wright D.N., Young L.S. In vitro activities of cefoperazone and sulbactam singly and in combination against cefoperazone-resistant members of the family Enterobacteriaceae and nonfermenters. Antimicrob. Agents Chemother. 34:1990;2256-2259.
6. Deguchi K., Yokota N., Koguchi M., et al. Synergy between sulbactam and ampicillin or cefoperazone in antimicrobial activity against beta-lactamase-producing microorganisms. Results with the use of microdiffusion broth method. Jpn. J. Antimicrob. 43:1990;1214-1224.
7. Zhang Y., Zhang J., Zhou L. In vitro antibacterial activity of cefoperazone-sulbactam. Zhonghua Nei Ke Za Zhi. 34:1995;676-679.
8. Shinagawa N., Takeda S., Ochira S., et al. Efficacy and safety of sulbactam/cefoperazone for hepato-biliary infections. Jpn. J. Antibiot. 50:1997;862-870.
9. Winston D.J., Bartoni K., Bruckner D.A., Schiller G.J., Territo M.C. Randomized comparison of sulbactam/cefoperazone with imipenem as empirical monotherapy for febrile granulocytopenic patients. Clin. Infect. Dis. 26:1998;576-583.
10. Greenberg R.N., Cayavec P., Danko L.S., et al. Comparison of cefoperazone plus sulbactam with clindamycin plus gentamicin as treatment for intra-abdominal infections. J. Antimicrob. Chemother. 34:1994;391-401.
11. Motojima S., Asakawa J., Ezure M., et al. Multicenter study of the effects of sulbactam/cefoperazone on bacterial infections in the fields of internal medicine focused mainly on respiratory infections in Tochigi Prefecture. Jpn. J. Antibiot. 46:1993;918-925.
12. Kitamura K., Takaku F., Miyazaki T., et al. Clinical evaluation of sulbactam/cefoperazone for severe infections associated with hematological disorders. Jpn. J. Antibiot. 44:1991;976-986.